| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2004-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63862e54d70e902b58607559d2bb9ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9105fcd9afe52845a3b07ed95d19256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f28666bc53b22981406880f8252ef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ed3956d55779980b148c4b4bab84c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bab966cf54c7ebecd2eb36c00b571bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_701a20bb52d8d0af1573787b1e70f627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35acb025b61d6e983d64d0a24bf60fab |
| publicationDate |
2005-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005032721-A1 |
| titleOfInvention |
Methods of administering dalbavancin for treatment of skin and soft tissue infections |
| abstract |
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular an uncomplicated Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005004050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009298749-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006074014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7119061-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143212-B2 |
| priorityDate |
2002-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |